Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Astellas Pharma Inc. Stories

2013-07-24 08:31:03

New initiative highlights the physical and emotional burden of overactive bladder through a unique mix of educational programs NORTHBROOK, Ill., July 24, 2013 /PRNewswire/ -- As part of its commitment to health education and awareness, Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), has launched a multifaceted initiative designed to raise awareness of overactive bladder (OAB)--an under-recognized, treatable medical...

2013-07-19 20:20:54

NORTHBROOK, Ill., July 19, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and Drug Administration (FDA) has approved ASTAGRAF XL(TM) (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. "Each transplant...

2013-07-03 12:24:06

Project Recognized for Outstanding Architecture and Community Enhancement LOS ANGELES, July 3, 2013 /PRNewswire/ -- HLW International earned recognition for its design of the Agensys Cancer Research Laboratory in Santa Monica, California. Agensys, Inc. is an affiliate of Astellas Pharma. The Los Angeles Business Council recognized the project for "outstanding architecture and design that significantly enhances the Los Angeles community's urban environment." The project, which will be...

2013-06-25 08:24:50

Event is part of the PGA TOUR's Women's Initiative, sponsored by Astellas, and is expected to attract more than 200 female leaders PITTSBURGH, Pa, and NORTHBROOK, Ill., June 25, 2013 /PRNewswire/ -- The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today will feature acclaimed researcher and author Dr. Helen Fisher at the Astellas Presents Executive Women's Day, a day-long forum focusing on professional,...

2013-06-24 08:28:31

NORTHBROOK, Ill., June 24, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced that the U.S. Food and Drug Administration (FDA) has approved its Supplemental New Drug Application (sNDA) for the use of MYCAMINE® (micafungin sodium) for injection by intravenous infusion for the treatment of pediatric patients four months and older with candidemia, acute disseminated candidiasis, Candida peritonitis...

2013-06-24 08:23:59

On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas BETHESDA, Md., and NORTHBROOK, Ill., June 24, 2013 /PRNewswire/ -- The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today will feature trailblazer sports agent Molly Fletcher at the Astellas Presents Executive Women's Day, a day-long forum focusing on professional, health-related and personal...

2013-06-05 08:28:39

NORTHBROOK, Ill., June 5, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the company has entered into a distribution agreement with Tecnofarma International Ltd. to distribute enzalutamide (XTANDI(®) in the U.S.) in Latin America, excluding Brazil, upon regulatory approvals in the various countries. Financial terms of the agreements were not disclosed. "We are pleased to initiate a...

2013-06-04 08:29:50

On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas MEMPHIS, Tenn. and NORTHBROOK, Ill., June 4, 2013 /PRNewswire/ -- The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today will feature trailblazer sports agent Molly Fletcher at the Astellas Presents Executive Women's Day, a day-long forum focusing on professional, health-related and personal...

2013-05-29 00:23:41

Innovative Joint Venture to Address Unmet Medical Needs of Patients in Japan THOUSAND OAKS, Calif. and TOKYO, May 29, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN), the world's largest independent biotechnology company, and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas"), a leading Tokyo-based global pharmaceutical company, today announced the companies have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese...

2013-05-21 08:26:03

On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas FORT WORTH, Texas and NORTHBROOK, Ill., May 21, 2013 /PRNewswire/ -- The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today will feature CBS sportscaster Lesley Visser at the Astellas Presents Executive Women's Day, a day-long forum focusing on professional, health-related and personal development...